Scientific Articles

NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial

 

Zev A Wainberg, MD – Davide Melisi, MD – Teresa Macarulla, MD – Roberto Pazo Cid, MD – Sreenivasa R Chandana, MD – Christelle De La Fouchardière, MD – Andrew Dean, MD – Igor Kiss, MD – Woo Jin Lee, MD – Thorsten O Goetze, MD – Eric Van Cutsem, MD – A Scott Paulson, MD – Tanios Bekaii-Saab, MD – Shubham Pant, MD – Richard A Hubner, MD –
Zhimin Xiao, MD – Huanyu Chen, PhD – Fawzi Benzaghou, MD – Eileen M O’Reilly, MD

The Lancet Journal, October 07, 2023

Abstract link

Privacy Overview
AIOM

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Analytics

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.